Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Next Deadline
57 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
September 27, 2025
Application History
43 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Mar 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 27, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jan 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 30, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Sep 5, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Sep 5, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Sep 5, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 5, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 4, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Mar 4, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Mar 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 26, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 22, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Sep 22, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Sep 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 20, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Mar 20, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Mar 20, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 27, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Aug 2, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 2, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 25, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 25, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 25, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 25, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 25, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 6, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 6, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 6, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 5, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 13, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Sep 13, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Sep 13, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Aug 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 7, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"